We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

    • NYSE:UNH

    Business

    UnitedHealth Group Projects Strong Growth for 2025 with Promising Financial Outlook

    UnitedHealth Group (NYSE: UNH) has announced optimistic financial projections for 2025, expecting revenues between $450 billion and $455 billion, with net earnings per share projected at $28.15 to $28.65. This growth reflects a 9.4% revenue increase over the past year and highlights the company’s strategic focus on innovative healthcare solutions and operational efficiency. As the upcoming Investor Conference approaches, investors are eager to learn more about UnitedHealth’s growth strategies and commitment to enhancing shareholder value.

    Posted on Jhon
    Business

    UnitedHealth Group Inc. Faces Antitrust Investigation Impacting Stock

    Insurer Lemonade warns of decreased profits due to increased spending, while UnitedHealth Group Inc. faces an antitrust investigation, causing its stock to fall. The Justice Department is examining the relationships between UnitedHealthcare and its Optum units, focusing on the impact of acquisitions on competitors and consumers. With a significant market presence, UnitedHealth has been under regulatory scrutiny before, and its recent stock drop and ongoing investigation are of interest to investors and industry observers.

    Posted on Jhon